Recent

% | $
Quotes you view appear here for quick access.

Omeros Corporation Message Board

  • rrtzrealmd rrtzrealmd Mar 7, 2014 10:26 AM Flag

    HAW!!! How desperate can a biotech be...

    ...to announce that they are able to administer a higher dose of whatever drug they are testing?...do they intend to charge by the pound?...HAW!!!...

    ...I mean, two weeks ago they actually announced dosing their FIRST patient in their HD trial!...well, now THAT"S news!...HAW!!!...I'm sure investors are just sweating with anticipation for whenever gOMER increases a dose or treats a patient!...

    ...I dunno but I suspect MOST people are more interested in gOMER releasing just a LITTLE data on EFFICACY!...

    ...well, I guess you could say that they already admitted stuff isn't working...there was the schizophrenia phase 2 PR where they claimed that "given the small sample size, efficacy conclusions cannot be drawn..." and where they didn't release ANY of the cognitive data -- in other words, the drug DIDN'T work...

    ...then there's all these silly PRs about being able to increase the dose -- in other words, the dose they're using ISN'T working...

    ...in the wonderful world of biotechs, it's best to learn the fine art of obfuscation BEFORE buying stock...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • They indicated the same when they started the trial, that cognitive testing would be done, but would be inclusive due to small sample size. Shame you didn't buy at sub-$5 like the smart money on the board.

    • They indicated the same when they started the trial, that cognitive testing would be done, but would be inclusive due to small sample size. Shame you didn't buy at sub-$5 like the smart money on the board.

      • 2 Replies to guatemelon73
      • ...specifically, gOMER said:

        "A variety of cognitive tests will be assessed, although the relatively small size of this trial will limit the ability to detect treatment effects, if present."

        ...small size or not, they EVIDENTLY were UNABLE to "detect treatment effects" -- i.e. DIDN"T work...they also elected not to reveal ANY of the data of the three cognitive tests they administered, from which you may infer that not only did it NOT work, it didn't even SUGGEST a difference from the placebo!...

        ...all of which is confirmed by the PR revealing that they are pursuing HIGHER doses -- pretty obviously HOPING they can find SOME dose which will produce an effect...

        ...EVEN THOUGH they already reported that the "medium" dose achieved an "average of 66 percent target interaction (a high of approximately 70 percent)"...well, gee, if binding TWO THIRDS of the receptors couldn't produce SOME evidence of an effect, how likely is it that an even higher dose will do anything?...

      • Isn't that's what is so funny about the donkey boy he was posting on this board when the stock was at $3.65 and could have bought and road it to $14. Instead he just kept posting is moronic statements and missed the biggest opp of his life.

        Realmd has not figured out that the stock market is about making money. What a FOOl. But it is fun to watch his ranting and see how upset he is that he missed a 300% gain

    • And to think you could have bought all you wanted at $3. This would have been the best investment you ever made and it was right in front of you. LOL -- simply pathetic. I LOVE IT that you are so bitter and can't move on!!!! SIMPLY LOVE IT!

    • Donkey boy is back time to buy!

      How desperate can someone be that after a stock goes from $3 to $13 and they have been screaming sell they are still whining.

 
OMER
13.250.00(0.00%)4:00 PMEDT